These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1097137)

  • 1. The LH response to LH releasing hormone in children with true isosexual precocious puberty treated with cyproterone acetate.
    Kauli R; Prager-Lewin R; Keret R; Laron Z
    Clin Endocrinol (Oxf); 1975 May; 4(3):305-11. PubMed ID: 1097137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The LH and FSH responses to LH-releasing hormone (LH-RH) in girls with true precocious puberty treated with cyproterone acetate.
    Kauli R; Prager-Lewin R; Keret R; Laron Z
    Eur J Pediatr; 1977 Jul; 125(3):205-12. PubMed ID: 328285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cyproterone acetate therapy on gonadotropin response to synthetic luteinizing hormone-releasing hormone (LRH) in girls with idiopathic precocious puberty.
    Angeli A; Boccuzzi G; Bisbocci D; Fonzo D; Frajria R; DeSanctis C; Ceresa F
    J Clin Endocrinol Metab; 1976 Mar; 42(3):551-60. PubMed ID: 767354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of medroxyprogesterone acetate on gonadotropin secretion in girls with precocious puberty.
    Warren MP; Mathews JH; Morishima A; Vande Wiele R
    Am J Med Sci; 1975; 269(3):375-81. PubMed ID: 1155493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of gonadotropins to stimulation with luteinizing hormone -- releasing hormone (LH-RH) in children with precocious puberty before, during and following therapy with cyproterone acetate or an ethisterone derivate.
    Frisch H; Kemeter P; Steinert I
    Padiatr Padol Suppl; 1977; (5):121-8. PubMed ID: 199874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules.
    Roger M; Chaussain JL; Berlier P; Bost M; Canlorbe P; Colle M; Francois R; Garandeau P; Lahlou N; Morel Y
    J Clin Endocrinol Metab; 1986 Apr; 62(4):670-7. PubMed ID: 2936759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responsivity of pituitary gonadotropes to luteinizing hormone-releasing factor in idiopathic precocious puberty, precocious thelarche, precocious adrenarche, and in patients treated with medroxyprogesterone acetate.
    Reiter EO; Kaplan SL; Conte FA; Grumbach MM
    Pediatr Res; 1975 Feb; 9(2):111-6. PubMed ID: 1090891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyproterone acetate in treatment of precocious puberty.
    Kauli R; Pertzelan A; Prager-Lewin R; Grünebaum M; Laron Z
    Arch Dis Child; 1976 Mar; 51(3):202-8. PubMed ID: 952553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single luteinizing hormone determination 2 hours after depot leuprolide is useful for therapy monitoring of gonadotropin-dependent precocious puberty in girls.
    Brito VN; Latronico AC; Arnhold IJ; Mendonca BB
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4338-42. PubMed ID: 15356030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous gonadotrophin pulsatility and ovarian morphology in girls with central precocious puberty treated with cyproterone acetate.
    Stanhope R; Pringle PJ; Adams J; Jeffcoate SL; Brook CG
    Clin Endocrinol (Oxf); 1985 Nov; 23(5):547-53. PubMed ID: 2935331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of precocious puberty with LHRH analogue in combination with cyproterone acetate-further experience.
    Kauli R; Pertzelan A; Ben-Zeev Z; Lewin RP; Kaufman H; Schally AM; Schally AV; Laron Z
    Clin Endocrinol (Oxf); 1984 Apr; 20(4):377-87. PubMed ID: 6232020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isosexual precocious puberty in girls.
    Lyon AJ; De Bruyn R; Grant DB
    Acta Paediatr Scand; 1985 Nov; 74(6):950-5. PubMed ID: 2936058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D-TRP5-analogue of luteinising hormone releasing hormone in combination with cyproterone acetate to treat precocious puberty.
    Laron Z; Kauli R; Zeev ZB; Comaru-Schally AM; Schally AV
    Lancet; 1981 Oct; 2(8253):955-6. PubMed ID: 6117727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of idiopathic precocious puberty with cyproterone acetate. Proceedings of a discussion, Berlin, April 29, 1977.
    Horm Res; 1978; 9(5):301-12. PubMed ID: 210100
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of children with central precocious puberty by a slow-release gonadotropin-releasing hormone agonist.
    Oostdijk W; Hümmelink R; Odink RJ; Partsch CJ; Drop SL; Lorenzen F; Sippell WG; van der Velde EA; Schultheiss H
    Eur J Pediatr; 1990 Feb; 149(5):308-13. PubMed ID: 2138079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of cyproterone acetate on the pituitary-gonadal system and other endocrine functions in female idiopathic precocious puberty].
    Koshimizu T
    Horumon To Rinsho; 1977 Sep; 25(9):989-97. PubMed ID: 923124
    [No Abstract]   [Full Text] [Related]  

  • 17. [Serum LH in healthy children and in precocious puberty].
    Butenandt O; Souvatzoglu A
    Monatsschr Kinderheilkd (1902); 1973 Jul; 121(7):473-4. PubMed ID: 4751491
    [No Abstract]   [Full Text] [Related]  

  • 18. A single sample subcutaneous luteinizing hormone (LH)-releasing hormone (LHRH) stimulation test for monitoring LH suppression in children with central precocious puberty receiving LHRH agonists.
    Lawson ML; Cohen N
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4536-40. PubMed ID: 10599714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate).
    Juul A; Scheike T; Nielsen CT; Krabbe S; Müller J; Skakkebaek NE
    J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis.
    Styne DM; Harris DA; Egli CA; Conte FA; Kaplan SL; Rivier J; Vale W; Grumbach MM
    J Clin Endocrinol Metab; 1985 Jul; 61(1):142-51. PubMed ID: 3923027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.